Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

Article

Indian healthcare reform offers thriving pharmaceutical market opportunities: Interview with Deepak Sapra

August 25, 2020

Global Pharma Insights spoke to Deepak Sapra (below), CEO of Active Pharmaceutical Ingredients and Services at Dr. Reddy's Laboratories for his perspective on the current state of the Indian healthcare and pharmaceuticals sector and how it is providing opportunities for both domestic and multinational drugmakers and healthcare providers despite the challenges of the ongoing coronavirus pandemic.

To read the interview click here

Contact Us

Please fill in the following form and we'll get back to you shortly.

Email us: api@drreddys.com | +91 40 49002253

Recent Articles

Formulation Strategies and Pharmaceutical Analysis for Anti-diabetic APIs Dec 02, 2024

Formulation Strategies and Pharmaceutical Analysis for Anti-diabetic APIs

API Quality Control Technologies & Strategies: Current Advancements for Benefiting Pharma Companies Dec 02, 2024

API Quality Control Technologies & Strategies: Current Advancements for Benefiting Pharma Companies

A year of growth & Sustainability Oct 09, 2024

A year of growth & Sustainability

View All

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.